Treasury Department's Proposed Rule on Outbound Investment Raises Concerns for U.S. Biopharmaceutical Development
Rapid Read

Treasury Department's Proposed Rule on Outbound Investment Raises Concerns for U.S. Biopharmaceutical Development

What's Happening? The Treasury Department's proposed rule to implement the Comprehensive Outbound Investment National Security (COINS) Act is raising concerns within the biopharmaceutical industry. According to Megan Van Etten, Vice President of Public Affairs at PhRMA, these regulations threaten to
AI Generated
This may include content generated using AI tools. Glance teams are making active and commercially reasonable efforts to moderate all AI generated content. Glance moderation processes are improving however our processes are carried out on a best-effort basis and may not be exhaustive in nature. Glance encourage our users to consume the content judiciously and rely on their own research for accuracy of facts. Glance maintains that all AI generated content here is for entertainment purposes only.